- Tension: Some 80-year-olds think like 50-year-olds, and scientists have long assumed it was just luck. A specific protein called REST is challenging that assumption entirely.
- Noise: We’ve built entire cultural and medical systems around the idea that cognitive decline is inevitable with age, but emerging molecular evidence suggests the brains of superagers are running a fundamentally different biological program.
- Direct Message: For the first time, the gap between sharp aging and cognitive decline has a molecular address, and it turns brain aging from an inevitability into a problem science may actually learn to solve.
To learn more about our editorial approach, explore The Direct Message methodology.
Margaret Chen was 83 when she beat her grandson at chess for the fourteenth consecutive time. Not a casual game, either. Her grandson, David, was 34, a software engineer in Seattle who spent his lunch breaks on Chess.com and considered himself serious about the game. He’d started keeping track after the fifth loss, convinced he was just having bad days. By the fourteenth, he stopped making excuses. His grandmother was simply sharper than he was.
Her neurologist in San Francisco, reviewing her latest cognitive assessment, used a word that stuck with David long after the appointment: “superager.” Margaret’s brain, at 83, was performing at the level of someone three decades younger. Her memory recall, processing speed, and executive function scores landed comfortably in the range of a typical 50-year-old. She wasn’t just aging well. Something in her brain appeared to be resisting the clock entirely.
For years, researchers assumed people like Margaret were simply lucky, the genetic lottery winners who happened to dodge Alzheimer’s and vascular damage. But a growing body of neuroscience is pointing to something far more specific: a single protein that appears to act as a kind of molecular shield, keeping certain brains from deteriorating the way most brains do. And its discovery is forcing scientists to rethink almost everything they believed about cognitive aging.
The protein is called REST, which stands for RE1-Silencing Transcription factor. It was first identified in the context of brain development, where it plays a role in regulating gene expression during fetal growth. For decades, nobody thought much about what it did in adult brains. Then, in a landmark study published in Nature, researchers at Harvard Medical School found that REST was dramatically more active in the brains of people who lived past 85 with their cognition intact compared to those who experienced significant decline (Yankner Lab, Nature, 2014). The difference wasn’t subtle. In post-mortem brain tissue, superagers showed REST levels that dwarfed those of their cognitively impaired peers.
What REST appears to do is suppress genes associated with neuronal stress, inflammation, and cell death. Think of it as a foreman on a construction site who keeps pulling workers back from the edge of an unstable building. Without enough REST, neurons become more vulnerable to the kind of oxidative damage and excitotoxicity that accumulates with age. With it, the brain seems to maintain a level of resilience that most people lose by their sixties.
Ronald DePinho, a cancer geneticist and former president of MD Anderson Cancer Center, has described the aging brain as a system under constant siege. “The question was never why brains decline,” he told an audience at a longevity conference in 2022. “The question is why some don’t.” REST may be the beginning of an answer.
Consider Tomás Herrera, a 79-year-old retired civil engineer in Tucson, Arizona. Tomás volunteers at a local community college, tutoring students in calculus. His wife, Elena, jokes that he remembers her grocery lists better than she does. When Tomás participated in a longitudinal aging study at the University of Arizona, researchers noted that his hippocampal volume (the brain region most associated with memory) had barely shrunk over a decade of MRI scans. Most people his age show measurable atrophy. Tomás’s brain tissue looked, by every imaging metric, like it belonged to someone in late middle age.
Researchers involved in the study couldn’t test his REST levels directly (that requires post-mortem analysis or cerebrospinal fluid sampling), but his cognitive profile matched the pattern seen in high-REST individuals from the Harvard data almost perfectly. As a recent piece on brain-protective proteins explored, the handful of people who maintain youthful cognition into their eighties and nineties aren’t just avoiding disease. Their brains appear to be running a fundamentally different biological program.
This is where the story gets complicated, because REST doesn’t exist in a vacuum. Its expression appears to be influenced by a tangle of factors, some genetic, some environmental, and some that researchers are only beginning to map. A 2019 study in Cell found that caloric restriction in animal models increased REST activity, suggesting that metabolic stress (the controlled kind) might trigger the protein’s protective effects (Zullo et al., Nature, 2019). Sleep quality, chronic inflammation, and even dietary patterns all appear to modulate how much REST the brain produces and how effectively it functions.
That connection to inflammation matters more than it might seem at first glance. We’ve covered how forever chemicals are now linked to faster biological aging, and one of the proposed mechanisms is chronic low-grade inflammation that erodes cellular repair systems over time. If REST is one of those repair systems, then the environmental toxins we absorb daily may be quietly undermining the very protein that keeps our brains young.
Naomi Watts, a 61-year-old nurse practitioner in Portland, Oregon, became fascinated with the superager research after watching her mother deteriorate from Alzheimer’s over seven years. “I kept asking her doctors what I should be doing now, in my fifties, to protect myself,” she said. “They all said the same thing: exercise, sleep, eat well. Which is fine. But it felt vague. Learning about REST gave me something specific to hold onto. It made the biology feel less like fate.”
Naomi’s instinct points to something real. The discovery of REST doesn’t automatically hand us a treatment or a pill. Nobody is injecting REST protein into patients (yet). But it reframes cognitive aging as something with identifiable molecular mechanisms, which means it’s potentially something we can intervene in. Several pharmaceutical companies and academic labs are now investigating compounds that could boost REST expression or mimic its neuroprotective effects. Bruce Bhatt, a neurobiologist at Columbia, has called REST “the most promising target in cognitive aging research in twenty years.”
The cultural implications run deeper than drug development, though. We’ve built an entire narrative around aging that treats cognitive decline as inevitable, as the natural tax for living long enough. We plan for it financially, emotionally, architecturally. Entire industries exist to manage the assumption that your brain will betray you if you stick around long enough. As we’ve explored in our coverage of how protein research could reshape cognitive decline treatment, the emerging science suggests that assumption is less universal than we think.
And the food we eat may matter more than we realize. Research on how ultra-processed foods activate addictive neural pathways raises the question of whether our dietary environment is actively working against the kind of metabolic conditions REST seems to thrive in. If the protein needs something like metabolic calm, or at least the absence of constant inflammatory provocation, then the modern food landscape is essentially a sabotage operation running twenty-four hours a day.
Margaret Chen doesn’t know what her REST levels are. She doesn’t track biomarkers or follow longevity podcasts. When David asked her once what she attributed her sharpness to, she thought about it for a long moment and said, “I never stopped being interested in things.” It’s a lovely answer, and it might even be part of the truth. Curiosity, novelty-seeking, and intellectual engagement have all been loosely associated with better cognitive outcomes in aging populations.
But the more precise truth is that Margaret’s brain is doing something at the molecular level that most people’s brains stop doing. She has more of a particular protein, or her body produces it more efficiently, or the conditions of her life have allowed it to persist in ways that remain partly mysterious. She’s not just lucky. She’s biologically different in a way that science can now name and measure, even if it can’t yet fully explain or replicate.
That’s the part that stays with you. For the first time, the gap between an 80-year-old who thinks like a 50-year-old and an 80-year-old who struggles to recall yesterday’s breakfast has a molecular address. REST won’t be the whole story. Biology never offers single explanations for complex phenomena. But it’s the first chapter of a story we’ve been waiting a very long time to read: the one where cognitive aging stops being a foregone conclusion and starts becoming a problem we might actually know how to solve.
Margaret is 84 now. David’s chess record against her stands at 0-17. He recently started playing with his own daughter, who’s seven. When she asked him why grandma always wins, he told her something that surprised even himself: “Because her brain decided not to get old.” He paused. “And maybe someday, we’ll know how to help everyone’s brain make that same decision.”
Feature image by www.kaboompics.com on Pexels
